Myskin Inc (MYSK) 4.5200 $MYSK
Brendan O'Brien Named to Strategic Advisory Board of Provectus Biopharmaceuticals, Inc.
ACCESSWIRE - Tue May 06, 9:38AM CDT
Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT), a biotech company specializing in developing oncology and dermatology therapies, announced today the appointment of Brendan O'Brien to its strategic advisory board.
MySkin, Inc. Enters Into A Management And Investment Agreement
PR Newswire - Wed Apr 30, 1:19PM CDT
MySkin, Inc. (OTCQB: MYSK) MYSKIN, INC., a California corporation, which intends to change its name to United Cannabis Corporation, and shall be referred to herein as ("UCANN"
, announced today it has entered into a management and investment agreement with a Nevada limited liability company (Nevco). Nevco, which has requested confidentiality as to its name while it is in the licensing process, is currently in the process of applying for a license to own and operate a registered and licensed medical marijuana dispensary, as defined by the Nevada Marijuana Laws, Nev. Rev. Stat. Section 453A.010 et seq. Nevco is developing distribution and retail lines and facilities that it represents are consistent with the research and production, growth and distribution and consulting and development objectives of UCANN.
CannabisFN Weekly: Volatility Drops as the Sector Begins to Stabilize
ACCESSWIRE - Mon Apr 21, 8:40AM CDT
The Marijuana Index(TM) was mixed last week after falling lower and then recovering towards the end of the shortened trading week.
La Quint Holdings Makes its Debut on the NYSE; Electronics Arts Hires Amy Hennig for Star Wars Project
ACCESSWIRE - Wed Apr 09, 11:44PM CDT
La Quinta Holdings Inc. (NYSE: LQ) - For an in-depth report on La Quinta Holdings Inc. follow: www.BullTrends.com/stockquote/LQ
MySkin, Inc. Acquires Medical Cannabis Expertise And Technology
PR Newswire - Tue Apr 01, 3:14PM CDT
MySkin, Inc. (OTC Quotation Board: MYSK) announced today that it has acquired intellectual property rights and technology being used in the medical cannabis industry. In addition, the three persons who licensed their know-how and technology to the Company have become executive officers. The technology includes designing and building commercial cannabis cultivation facilities, cultivation and retail operating procedures, nutrition methodologies, and a cannabinoid therapy program that utilizes the entire cannabis plant controlling specific cannabinoid ratios, accurate dosing, and multiple delivery methods. The intellectual property, technology, and methodologies acquired are for the production and extraction of full plant cannabis into individualized cannabinoid-based products with medical applications focused on sublingual, dietary, inhalation, transdermal, and drop delivery systems.
Yahoo Director John Hayes to Step Down; MannKind Corp.'s Afrezza Device Raises Concerns with the FDA
ACCESSWIRE - Sun Mar 30, 11:15PM CDT
Yahoo! Inc. (NASDAQ: YHOO) - For an in-depth report on Yahoo! Inc. follow: www.BullTrends.com/stockquote/YHOO
MySkin, Inc. Announces A Four-For-One Stock Split
PR Newswire - Fri Mar 21, 8:00AM CDT
MySkin, Inc. (OTCBB: MYSK) today announced that its Board of Directors has approved a four-for-one stock split of its outstanding Common Stock. The stock split will be effected in the form of a stock dividend of three shares of Common Stock for each share of Common Stock outstanding. The additional shares issued as a result of the stock split will be distributed on or about March 21, 2014 to stockholders of record on March 19, 2014.
Brendan O'Brien Named to Strategic Advisory Board of Provectus Biopharmaceuticals, Inc.
ACCESSWIRE - Tue May 06, 9:38AM CDT
Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT), a biotech company specializing in developing oncology and dermatology therapies, announced today the appointment of Brendan O'Brien to its strategic advisory board.
MySkin, Inc. Enters Into A Management And Investment Agreement
PR Newswire - Wed Apr 30, 1:19PM CDT
MySkin, Inc. (OTCQB: MYSK) MYSKIN, INC., a California corporation, which intends to change its name to United Cannabis Corporation, and shall be referred to herein as ("UCANN"
, announced today it has entered into a management and investment agreement with a Nevada limited liability company (Nevco). Nevco, which has requested confidentiality as to its name while it is in the licensing process, is currently in the process of applying for a license to own and operate a registered and licensed medical marijuana dispensary, as defined by the Nevada Marijuana Laws, Nev. Rev. Stat. Section 453A.010 et seq. Nevco is developing distribution and retail lines and facilities that it represents are consistent with the research and production, growth and distribution and consulting and development objectives of UCANN. CannabisFN Weekly: Volatility Drops as the Sector Begins to Stabilize
ACCESSWIRE - Mon Apr 21, 8:40AM CDT
The Marijuana Index(TM) was mixed last week after falling lower and then recovering towards the end of the shortened trading week.
La Quint Holdings Makes its Debut on the NYSE; Electronics Arts Hires Amy Hennig for Star Wars Project
ACCESSWIRE - Wed Apr 09, 11:44PM CDT
La Quinta Holdings Inc. (NYSE: LQ) - For an in-depth report on La Quinta Holdings Inc. follow: www.BullTrends.com/stockquote/LQ
MySkin, Inc. Acquires Medical Cannabis Expertise And Technology
PR Newswire - Tue Apr 01, 3:14PM CDT
MySkin, Inc. (OTC Quotation Board: MYSK) announced today that it has acquired intellectual property rights and technology being used in the medical cannabis industry. In addition, the three persons who licensed their know-how and technology to the Company have become executive officers. The technology includes designing and building commercial cannabis cultivation facilities, cultivation and retail operating procedures, nutrition methodologies, and a cannabinoid therapy program that utilizes the entire cannabis plant controlling specific cannabinoid ratios, accurate dosing, and multiple delivery methods. The intellectual property, technology, and methodologies acquired are for the production and extraction of full plant cannabis into individualized cannabinoid-based products with medical applications focused on sublingual, dietary, inhalation, transdermal, and drop delivery systems.
Yahoo Director John Hayes to Step Down; MannKind Corp.'s Afrezza Device Raises Concerns with the FDA
ACCESSWIRE - Sun Mar 30, 11:15PM CDT
Yahoo! Inc. (NASDAQ: YHOO) - For an in-depth report on Yahoo! Inc. follow: www.BullTrends.com/stockquote/YHOO
MySkin, Inc. Announces A Four-For-One Stock Split
PR Newswire - Fri Mar 21, 8:00AM CDT
MySkin, Inc. (OTCBB: MYSK) today announced that its Board of Directors has approved a four-for-one stock split of its outstanding Common Stock. The stock split will be effected in the form of a stock dividend of three shares of Common Stock for each share of Common Stock outstanding. The additional shares issued as a result of the stock split will be distributed on or about March 21, 2014 to stockholders of record on March 19, 2014.
